There isn't a worse service out there for investors who are looking to capitalize on the undervalued and overlooked opportunities from across the markets, these guys just keep delivering losing reports to their members.
If it was, I think they would have removed the reference to it in the corp presentation. Why the process is taking this long, even taking into account the hold and protocol changes, is beyond me.
Considering the success of the canine osteosarcoma and PII cervical cancer trials, I think proof of concept is pretty well proven. Now, as we know, nothing is infallible but the science failing is the least of my worries.
That was me, "Feb 24 Sachs Cancer BioPartnering & Investment Forum." Did not see this on the company site.
He's probably shacking up with Mikey in his trailer, both on public assistance.